Faculty Information - Tomohiro Oishi

Present specialized field

Journal

Presentation

（Last updated : 2026-05-22 15:18:01）

Tomohiro Oishi
Department Kawasaki Medical School Kawasaki Medical School, Department of Clinical Infectious Diseases,

Position Professor

■ Present specialized field

Embryonic medicine and pediatrics

■ Journal

1.	2026/04/30	Evaluation of Mumps-Specific Neutralizing Antibodies Compared with Immunoglobulin G in Japanese Children After the Coronavirus Disease Pandemic
2.	2026/01/13	Analysis of Macrolide Resistance in Bordetella pertussis Isolated from Japanese Children in 2025 Using Test Kit and Sequence Method
3.	2025/10	Nationwide surveillance of bacterial pathogens isolated from children by the surveillance committee of the Japanese society of chemotherapy, Japanese association for infectious diseases, and Japanese society for clinical microbiology between April 2021 and March 2024: General overview of pathogenic antimicrobial susceptibility
4.	2025/09/25	Macrolide-Resistant Mycoplasma pneumoniae Among Japanese Children from 2008 to 2024
5.	2025/03/17	Efficacy of baloxavir marboxil as a prophylactic against influenza among in-patients and analysis of influenza virus mutations in their isolates at a Japanese hospital during the 2023-2024 flu season
6.	2024/05/13	Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT^®.COVID
7.	2024/03/13	Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan
8.	2024/01/24	Novel Knowledge of Macrolide Resistance in Mycoplasma pneumoniae by Azithromycin Exposure
9.	2023/06/19	Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains
10.	2022/12/06	Recent Trend of Antimicrobial Susceptibility among Mycoplasma pneumoniae Isolated from Japanese Children
11.	2022/03/24	Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae
12.	2022/01	Characteristics and etiology of infection in febrile infants aged ≤90 days
13.	2021/10	Epidemiology of urinary tract infections in children: Causative bacteria and antimicrobial therapy.
14.	2021/09/22	Study of Normal Flora in the Pharynx of Healthy Children.
15.	2021/02	Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment
16.	2021/02	Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children
17.	2020/12/04	Reactive oxygen metabolites as a biomarker of congenital heart disease in children
18.	2020/11	Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan
19.	2020/10/02	Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan
20.	2019/07	Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods
21.	2019/02	LAMP-based assay can rectify the diagnosis of Yersinia pseudotuberculosis infections otherwise missed by serology
22.	2018/11	Incidence of Viremia With DNA Viruses in Oncology Patients With Febrile Neutropenia
23.	2017/11	Changes of Antibody Associated with Cell-Mediated Immunity in College Students During Two Years after Rubella Vaccination
24.	2017/11	Prevalence of skin infections caused by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Japan, particularly in Ishigaki, Okinawa.
25.	2017/10	Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015
26.	2017/08	Cellular and humoral immunity after vaccination or natural mumps infection
27.	2017/05	Histological findings in severe Mycoplasma pneumoniae pneumonia.
28.	2017/01	Corynebacterium striatum bacteremia associated with a catheter-related blood stream infection
29.	2016/05	Human parechovirus type 3 infection: Cause of apnea in infants born prematurely.
30.	2015/11	Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.
31.	2015/11	Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus
32.	2015/09	Asymptomatic children might transmit human parechovirus type 3 to neonates and young infants.
33.	2014/05	Japanese Invasive Disease Study Group. Characteristics of group B Streptococcus isolated from infants with invasive infections: a population-based study in Japan.
34.	2014/04	Impact of rotavirus vaccination on outpatient visits due to severe rotavirus gastroenteritis observed at three pediatric primary care clinics in Shibata City, Niigata Prefecture, Japan.
35.	2014/04	The Occurrence of Severe Rotavirus Gastroenteritis in Children under Three Years of Age before and after the Introduction of Rotavirus Vaccine--A Prospective Observational Study in Three Pediatric Clinics in Shibata-City,Niigata Prefecture,Japan.
36.	2014/02	Clinical utility of loop-mediated isothermal amplification for rapid diagnosis of Mycoplasma pneumoniae in children.
37.	2013/05	Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.Vaccine
38.	2012/05	Rhabdomyolysis by drug-resistant Mycoplasma pneumoniae with elevated levels of IL-18 and TNF-a.
39.	2012/02	A practical approach estimating etiologic agents using real-time PCR in pediatric inpatients with community-acquired pneumonia.
40.	2011/06	Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia.
41.	2011/04	Serotyping and multilocus sequence typing of Streptococcus pneumoniae isolates from blood and the posterior nare of Japanese children prior to the introduction of 7-valent pneumococcal conjugate vaccine,
42.	2011/01	Prophylactic cefdinir for pediatric cases of complicated urinary tract infection.
43.	2009/06	Nationwide survey of the development of drug-resistance in the pediatric field: drug sensitivity of Haemophilus influenzae in Japan
44.	2009/06	Nationwide survey of the development of drug-resistant pathogens in the pediatric field: drug sensitivity of Streptococcus pneumoniae in Japan
45.	2007/07	Investigation of Streptococcus pneumoniae and Haemophilus influenzae isolated from pediatric outpatients nationwide with a respiratory tract infection at the first consultation (2002-2003)--with special reference to the results of nasopharyngeal culture in pediatric patients with no previous history of antibacterial drug administration
46.	2004/01	Double-blind comparative study on the care of the neonatal umbilical cord using 80% ethanol with or without chlorhexidine.
Display 5 items
Display all(46)

■ Presentation

1.	2021/11/04	Recent Trend of Pediatric Mycoplasma pneumoniae lnfections in Japan. （Speech，Panelist at Symposium/Workshop (Appointed)）
2.	2019/06/28	The nationwide survey of Mycoplasma pneumoniae infection in children throughout Japan in recent 10 years （Poster notice，General）
3.	2018/11/17	Detection of Bacteria, Fungi, and Viruses by a Real-time PCR assay using universal primers and probes from Blood in Patients with Febrile Neutropenia. （Poster notice，General）
4.	2018/11/14	Two cases of intenstinal primary mature B cell lymphoma of elderly children with intussusception （Poster notice，General）
5.	2018/11/12	Identical group A streptococcus (GAS) isolated from a mother suffering perinatal invasive GAS infection and her twin neonates developing acute otitis media. （Speech，General）
6.	2018/11/11	THE EPIDEMICAL FEATURES OF MYCOPLASMA PNEUMONIA INFECTION AMONG CHILDREN THROUGHOUT JAPAN IN THE RECENT 10 YEARS （Speech，Panelist at Symposium/Workshop (Appointed)）
7.	2018/07/12	THE EPIDEMICAL FEATURES OF MYCOPLASMA PNEUMONIA INFECTION AMONG CHILDREN THROUGHOUT JAPAN IN THE RECENT 10 YEARS. （Speech，General）
8.	2018/07/02	Nationwide survey of Chlamydia pneumoniae infections and Mycoplasma pneumoniae infections in children in Japan 2008-2017 （Poster notice，General）
9.	2018/05/19	Symposium 4. Clinical aspects of Mycoplsma pneumoniae pneumonia The epidemical features of Mycoplasma pneumoniae infection among children throughout Japan in recent 10 years （Speech，Panelist at Symposium/Workshop (Appointed)）
10.	2018/05/08	Nationwide survey of Mycoplasma pneumoniae infections and Chlamydia pneumoniae infections in children in Japan 2008-2017 （Poster notice，General）
11.	2017/11/10	Frequency of Human Herpes Viruses 1-7, BV Virus and Human Parvovirus B19 in Patients with Febrile Neutropenia by Real-time PCR （Poster notice，General）
12.	2016/06/13	Epidemiological And Clinical Investigation of Mycoplasma pneumonia Infection in Children Throughout Japan between 2008 and 2014. 21st Congress of the International Organization for Mycoplasmology. Brisbane, Australia 2016 （Poster notice，General）
Display 5 items
Display all(12)